Skip to content

Mechanism of Action of Milk and Its Components on Glycemic Control in Healthy Young Men

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01812967
Enrollment
12
Registered
2013-03-18
Start date
Unknown
Completion date
Unknown
Last updated
2013-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glycemic Control, Gastrointestinal Hormone Response, Healthy Young Men

Brief summary

The investigators hypothesize that the physiological effects of milk on satiety and glycemic control are mediated by the interaction between its macronutrient components by both insulin-dependent and independent mechanisms.

Interventions

DIETARY_SUPPLEMENTMilk Fat
DIETARY_SUPPLEMENTMilk Protein
DIETARY_SUPPLEMENTLactose
OTHERWhole milk (3.25% M.F.(

Commercially available milk from the grocery store

DIETARY_SUPPLEMENTSimulated Milk Beverage

Added lactose + fat + protein together to form a mixture

Sponsors

University of Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION

Eligibility

Sex/Gender
MALE
Age
20 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy young men * 20-30 years of age * BMI: 20-24.9 kg/m2

Exclusion criteria

* Smoking * Dieting * Skipping breakfast * Lactose intolerance or allergies to milk * Taking medications that may affect glucose metabolism or appetite * Diabetes (fasting blood glucose ≥ 7.0 mmol/L) or other metabolic diseases

Design outcomes

Primary

MeasureTime frame
Glucose0-180 min

Secondary

MeasureTime frame
Insulin0-180 min

Other

MeasureTime frameDescription
Gastrointestinal hormones and gastric emptying rate0-180 minGatrointestinal hormones measured include plasma concentrations of glucagon-like peptide-1 (GLP-1), peptide tyrosine tyrosine (PYY), cholecystokinin (CCK), and ghrelin. Gastric emptying is assessed indirectly by adding 1.5 g of paracetamol (acetaminophen) to each beverage and measuring plasma paracetamol concentrations.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026